Results 71 to 80 of about 1,233,301 (210)

RE: ASK1, a new target in treating cardiorenal syndrome (CRS)

, 2023
RE: ASK1, a new target in treating cardiorenal syndrome ...
A J Edgley (13407291), Feby Savira (13069731), D J Kelly (13028308), A R Kompa (13407294), B H Wang (13363860), B M Jucker (13407270), R N Willette (13407273)   +6 more
core  

Improving Prognosis Estimation in Patients with Heart Failure and the Cardiorenal Syndrome

International Journal of Nephrology, 2011
The coexistence of heart failure and renal dysfunction constitutes the “cardiorenal syndrome” which is increasingly recognized as a marker of poor prognosis.
Husam M. Abdel-Qadir, Shaan Chugh, Douglas S. Lee   +2 more
doaj   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Pharmacologic diuresis is safer than ultrafiltration for cardiorenal syndrome [PDF]

, 2016
A critical appraisal and clinical application of Bart BA, Goldsmith SR, Lee KL et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367:2296-2304.
Choong, Grace
core   +1 more source

Data on the stem cells paracrine effects on apoptosis and cytokine milieu in an experimental model of cardiorenal syndrome type II

Data in Brief, 2018
The data reported in this article are related to the paper entitle “Stem cells transplantation positively modulates the heart-kidney cross talk in Cardiorenal Syndrome Type II” (Vescovo et al., 2019), which analyzed the impact of stem cells injection in ...
Giorgio Vescovo, Chiara Castellani, Marny Fedrigo, Grazia Maria Virzì, Giovanni Maria Vescovo, Regina Tavano, Michela Pozzobon, Annalisa Angelini   +7 more
doaj   +1 more source

The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic

Diabetic Medicine, EarlyView.
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo, Bianca Aparecida Siqueira, Luiz Felipe Azevedo Marques, Lucas Silva Mello, Fernando Augusto Lima Marson   +4 more
wiley   +1 more source

First-in-Man Use of the Percutaneous 10F Reitan Catheter Pump for Cardiorenal Syndrome

, 2022
Cardiorenal syndrome worsens outcome in patients with decompensated chronic heart failure, and complicates recompensation by medical therapy. Mechanical circulatory support has the potential to improve renal function, and likely mitigates diuretic ...
Silvia Mariani (7771772), Arjang Ruhparwar (87186), Guenes Dogan (16665951), Jan D. Schmitto (15314618), Jasmin S. Hanke (16665948), Axel Haverich (295514), Bastian Schmack (607063), Oyvind Reitan (16659387), Lars C. Napp (16665945), Thomas R. Keeble (14125403), Johann Bauersachs (141016), Marcus Hiss (16665954)   +11 more
core   +3 more sources

Síndrome cardiorrenal na insuficiência cardíaca aguda: um círculo vicioso?

Revista Portuguesa de Cardiologia, 2014
Resumo: Introdução e objetivos: O valor prognóstico da deterioração da função renal é indiscutível nos doentes com insuficiência cardíaca aguda. No contexto nacional sabe‐se pouco acerca do peso relativo da síndrome cardiorrenal no internamento destes ...
Francisca Caetano, Sérgio Barra, Ana Faustino, Ana Botelho, Paula Mota, Marco Costa, António Leitão Marques   +6 more
doaj   +1 more source

Early sodium‐glucose co‐transporter 2 inhibitor initiation is associated with improved cardiovascular outcomes in type 2 diabetes and acute coronary syndrome

Diabetic Medicine, EarlyView.
Abstract Aims Sodium‐glucose co‐transporter 2 inhibitors have demonstrated cardiovascular benefits in individuals with type 2 diabetes mellitus, but the optimal timing of initiation in those with acute coronary syndrome is not known. This study aims to assess if early therapy at discharge is superior to delayed or no therapy in reduction in major ...
Muhammad Usman Shah, Joanna Kate Ward, Alun Roebuck, Bala Srinivasan, Paul Edward Squires, Claire Elizabeth Hills, Maxime Inghels, Kelvin Lee   +7 more
wiley   +1 more source

Cardiorenal Syndrome [PDF]

Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica MoldovaIntroduction. Cardiorenal syndrome (CRS) is a condition characterized by the complex bidirectional relationship between the heart and kidneys, leading to ...
Kousa O, Rout P, Aslam A, Aboeata A.
europepmc   +2 more sources